NCT01960855 2021-08-24A Study Investigating the Efficacy and Safety of ABT-494 Given With Methotrexate in Subjects With Rheumatoid Arthritis Who Failed Anti-Tumor Necrosis Factor (TNF) Biologic TherapyAbbViePhase 2 Completed276 enrolled 14 charts